Home / Stocks / PRME

PRME insider trading

Prime Medicine, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
11
Bought · 24 mo
$35.4M
Buys · last 90 days
0 · $0
Most recent buy
2025-08-05

Cluster buy detected

4 insiders bought PRME within a short window (2025-05-20→2025-06-30), $447k in total — cluster score 73/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-08-05Alphabet Inc.
10% owner
Bought1,500,000$3.30$5.0M
2025-08-01NELSEN ROBERT
Director · 10% owner
Bought3,030,300$3.30$10.0M
2025-08-01ARCH Venture Fund XII, L.P.
10% owner
Bought3,030,300$3.30$10.0M
2025-08-01ARCH Venture Fund X Overage, L.P.
10% owner
Bought3,030,300$3.30$10.0M
2025-07-01Liu David R.cluster
10% owner
Bought21,000$2.52$53k
2025-06-23Liu David R.cluster
10% owner
Bought21,000$2.16$45k
2025-06-16Liu David R.cluster
10% owner
Bought21,000$1.49$31k
2025-06-12Liu David R.cluster
10% owner
Bought21,000$1.60$34k
2025-05-22Brudnick Richardcluster
Chief Business Officer
Bought20,000$1.19$24k
2025-05-22LEE ANN L.cluster
Chief Technical Officer
Bought100,000$1.13$113k
2025-05-22Reine Allancluster
Chief Executive Officer
Bought125,000$1.18$148k

Most active insider buyers

InsiderRoleBuysTotal bought
NELSEN ROBERTDirector · 10% owner1$10.0M
ARCH Venture Fund XII, L.P.10% owner1$10.0M
ARCH Venture Fund X Overage, L.P.10% owner1$10.0M
Alphabet Inc.10% owner1$5.0M
Liu David R.10% owner4$163k
Reine AllanChief Executive Officer1$148k

See PRME on the chart

Every insider buy and sell for PRME plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.